anmelden
FTSE All-Share
5.721,53
PKT
-13,93
PKT
-0,24
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.11.16 | BP Hold | Deutsche Bank AG | |
| 02.11.16 | Shell (ex Royal Dutch Shell) Conviction Buy | Goldman Sachs Group Inc. | |
| 02.11.16 | BP Neutral | Goldman Sachs Group Inc. | |
| 02.11.16 | BP Neutral | UBS AG | |
| 02.11.16 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 02.11.16 | BP Hold | S&P Capital IQ | |
| 01.11.16 | Shell (ex Royal Dutch Shell) buy | S&P Capital IQ | |
| 01.11.16 | HSBC Neutral | Goldman Sachs Group Inc. | |
| 01.11.16 | HSBC Hold | Deutsche Bank AG | |
| 01.11.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 31.10.16 | Rio Tinto overweight | JP Morgan Chase & Co. | |
| 31.10.16 | Barclays Neutral | UBS AG | |
| 28.10.16 | AstraZeneca buy | Deutsche Bank AG | |
| 28.10.16 | BT Group Sell | Deutsche Bank AG | |
| 28.10.16 | Barclays Equal-Weight | Morgan Stanley | |
| 28.10.16 | Lloyds Banking Group Hold | Deutsche Bank AG | |
| 28.10.16 | Imperial Brands buy | Deutsche Bank AG | |
| 28.10.16 | BT Group Neutral | JP Morgan Chase & Co. | |
| 28.10.16 | Rio Tinto Outperform | Macquarie Research | |
| 28.10.16 | Barclays Neutral | JP Morgan Chase & Co. | |
| 28.10.16 | Barclays buy | Société Générale Group S.A. (SG) | |
| 28.10.16 | BAT buy | Société Générale Group S.A. (SG) | |
| 28.10.16 | BT Group Conviction Buy | Goldman Sachs Group Inc. | |
| 28.10.16 | BT Group buy | HSBC | |
| 28.10.16 | Imperial Brands buy | Goldman Sachs Group Inc. | |
| 27.10.16 | Barclays Hold | S&P Capital IQ | |
| 27.10.16 | GSK Hold | Deutsche Bank AG | |
| 27.10.16 | Lloyds Banking Group buy | UBS AG | |
| 27.10.16 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 27.10.16 | BT Group Hold | S&P Capital IQ | |
| 27.10.16 | GSK buy | Goldman Sachs Group Inc. | |
| 27.10.16 | GSK Neutral | UBS AG | |
| 27.10.16 | Rio Tinto overweight | JP Morgan Chase & Co. | |
| 27.10.16 | Lloyds Banking Group Neutral | JP Morgan Chase & Co. | |
| 27.10.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 26.10.16 | Rio Tinto overweight | JP Morgan Chase & Co. | |
| 26.10.16 | Lloyds Banking Group buy | S&P Capital IQ | |
| 26.10.16 | BAT overweight | JP Morgan Chase & Co. | |
| 26.10.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 26.10.16 | Rio Tinto buy | Deutsche Bank AG |